Galanin pp 151-176 | Cite as

An overview of galanin’s actions on the endocrine pancreas

  • T. J. McDonald
  • B. Tinner
  • W. A. Staines
  • J. Radziuk
Part of the Wenner-Gren Center International Symposium Series book series


During studies to determine the primary structure of porcine cholecystokinin-pancreozymin (CCK), Mutt and Jorpes (1967) noted that the C-terminal dipeptide amide, aspartyl-phenylalanine amide, could be cleaved from the parent molecule and chromatographically separated from other peptide fragments. From this observation it was reasoned that the development of a general methodology to unequivocally identify and quantitate the individual C-terminal amide structures present in certain regulatory peptides, could provide the basis for an assay system for such regulatory peptides (Mutt, 1973). Tatemoto and Mutt (1978) devised a method whereby C-terminal alpha-amide structures are enzymatically cleaved from their parent biologically active peptides present in crude tissue extracts; following which, these liberated structures are chromatographically isolated, allowing precise identification of the amide structures and their quantitation. They demonstrated that their assay system could be used to follow the purification of known peptides from porcine intestinal extracts but, more importantly, they noted the presence in their tissue extracts of a number of C-terminal alpha-amide structures which could not have arisen from any regulatory peptide known at that time.


Insulin Secretion Glucagon Secretion Endocrine Pancreas Galanin Receptor Inhibit Insulin Secretion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ahrén, B., Arkhammar, P., Berggren, P.-O., and Nilsson, T. (1986). Galanin inhibits glucose-stimulated insulin release by a mechanism involving hyperpolarization and lowering of cytoplasmic free Ca2+ concentration. Biochem. Biophys. Res. Com., 140, 3, 1059–1063.PubMedCrossRefGoogle Scholar
  2. Ahrén, B., Veith, R.C., and Taborsky, G.J. (1987). Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog. 1. Effects on basal release of insulin and glucagon. Endocrinology. 121, 323–331.PubMedCrossRefGoogle Scholar
  3. Ahrén, B., Martensson, H., and Ekman, R. (1989). Pancreatic nerve stimulation releases neuropeptide Y-but not galanin-or calcitonin gene-related peptide-like immunoreactivity from the pig pancreas. J. Aut. Nerv. Syst., 27, 11–16.CrossRefGoogle Scholar
  4. Ahrén, B., Bottcher, G., Kowalyk, S., Dunning, B.E., Sundler, F., and Taborsky, G.J., Jr. (1990). Galanin is co-localized with norepinephrine and neuropeptide Y (NPY) in dog pancreas and celiac ganglion. Diabetes. 39, Suppl. 1, 542A.Google Scholar
  5. Amiranoff, B., Servin, A.L., Rouyer-Fessard, C., Couvineau, A., Tatemoto, K., and Laburthe, M. (1987). Galanin receptors in a hamster pancreatic β-cell tumor: identification and molecular characterization. Endocrinology. 121, 284–289.PubMedCrossRefGoogle Scholar
  6. Amiranoff, B., Lorinet, A.-M., Lagny-Pourmir, I., and Laburthe, M. (1988). Mechanism of galanin-inhibited insulin release. Occurrence of a pertussis-toxin-sensitive inhibition of adenylate cyclase. Eur. J. Biochem., 177, 147–152.PubMedCrossRefGoogle Scholar
  7. Amiranoff, B., Lorinet, A.-M., Yanaihara, N., and Laburthe, — M. (1989). Structural requirement for galanin action in the pancreatic ß cell line Rin m5F. Eur. J. Pharmacol., 163, 205–207.PubMedCrossRefGoogle Scholar
  8. Amiranoff, B., Lorinet, A.M., and Laburthe, M. (1989). Galanin receptor in the rat pancreatic ß cell line Rin m5F. Molecular characterization by chemical cross-linking. J. Bioloq. Chem., 264, 20714–20717.Google Scholar
  9. Bauer, F.E., Ginsberg, L., Venetikou, M., MacKay, D.J., Burrin, J.M., and Bloom, S.R. (1986a). Growth hormone release in man induced by galanin, a new hypothalamic peptide. Lancet. 2, 192–194.PubMedCrossRefGoogle Scholar
  10. Bauer, F.E., Adrian, T.E., Christofides, N.D., Ferri, G.-L., Yanaihara, N., Polak, J.M., and Bloom, S.R. (1986b). Distribution and molecular heterogeneity of galanin in human, pig, guinea pig, and rat gastrointestinal tracts. Gastroenterology, 91, 877–883.PubMedGoogle Scholar
  11. Bauer, F.E., Hacker, H.W., Terenghi, G., Adrian, T.E., Polak, J.M., and Bloom, S.R. (1986c). Localization and molecular forms of galanin in human adrenals: elevated levels in pheochromocytomas. J. Clin. Endocrinol. Metab., 63, 1372–1378.PubMedCrossRefGoogle Scholar
  12. Bauer, F.E., Zintel, A., Kenny, M.J., Calder, D., Ghatei, M.A., and Bloom, S.R. (1989). Inhibitory effect of galanin on postprandial gastrointestinal motility and gut hormone release in humans, Gastroenterology. 97, 260–264.PubMedGoogle Scholar
  13. De Neille, J., Schmid-Antomarchi, H., Fosset, M., and Lazdunski, M. (1988). ATP-sensitive K+ channels that are blocked by hypoglycemia-inducing sulfonylureas in insulin-secreting cells are activated by galanin, a hyperglycemia-inducing hormone. Proc. Natl. Acad. Sci. USA. 85, 1312–1316.CrossRefGoogle Scholar
  14. Dunne, M.J., Bullett, M.J., Li, G., Wollheim, C.B., and Petersen, O.H. (1989). Galanin activates nucleotide-dependent K+ channels in insulin-secreting cells via a pertussis toxin-sensitive G-protein. The EMBO Journal, 8, 413–420.PubMedPubMedCentralGoogle Scholar
  15. Dunning, B.E., Ahrén, B., Veith, R.C., Bottcher, G., Sundler, F., Taborsky, J.R. (1986a) Galanin: a novel pancreatic neuropeptide. Am. J. Physiol. 251. E127–E133.PubMedGoogle Scholar
  16. Dunning, B.E., Ahrén, B., Taborsky, G.J. Jr. (1986b) Further evidence that norepinephrine does not mediate neural inhibition of basal insulin secretion (Abstract) In 68th Annu. Meet. Endocrine Soc., 1986 p 109.Google Scholar
  17. Dunning, B.E., Ahrén, B., Veith, R.C., and Taborsky, G.J. Jr.(1988). Nonadrenergic sympathetic neural influences on basal pancreatic hormone secretion. Am. J. Physiol., 255, E785–E792.PubMedGoogle Scholar
  18. Dunning, B.E., and Taborsky, G.J., Jr. (1989). Galanin release during pancreatic nerve stimulation is sufficient to influence islet function. Am. J. Physiol., 256, E191–198.PubMedGoogle Scholar
  19. Dunning, B.E., Havel, P.J., Veith, R.C., and Taborsky, G.J., Jr. (1990). Pancreatic and extrapancreatic galanin release during sympathetic neural activation. Am. J. Phvsiol., 258, E436–444.Google Scholar
  20. Ekblad, E., Hakanson, R., Sundler, F., and Wahlestedt, C. (1985). Galanin: neuromodulatory and direct contractile effects on smooth muscle preparations. Br. J. Pharmac., 86, 241–246.CrossRefGoogle Scholar
  21. Fisone, G., Berthold, M., Bedecs, K., Undén, A., Bartfai, T., Bertorelli, R., Consolo, S., Crawley, J., Martin, B., Nilsson, S., and Hokfelt, T. (1989). N-terminal galanin-(1–16) fragment is an agonist at the hippocampal galanin receptor. Proc. Natl. Acad. Sci. USA. 86, 9588–9591.PubMedPubMedCentralCrossRefGoogle Scholar
  22. Fox, J.E.T., Brooks, B.D., McDonald, T.J., Barnett, W., Kostalanska, F., Rokaeus, A., St-Pierre, S., Yanaihara, C. and Yanaihara, N. (1988). Actions of galanin fragments on rat, guinea-pig and canine intestinal motility. Gastroenterology. 94, A134.Google Scholar
  23. Gilbey, S.T., Stephenson, J., O’Halloran, D.J., Burrin, J.M., and Bloom, S.R. (1989). High-dose porcine galanin infusion and effect on intravenous glucose tolerance in humans. Diabetes. 38, 1114–1116.PubMedCrossRefGoogle Scholar
  24. Greenberg, G.R., and McDonald, T.J. (1988). Effect of galanin and vagal integrity on insulin release in dogs. Pancreas, 3, 122–127.PubMedCrossRefGoogle Scholar
  25. Hermansen, K. (1988). Effects of galanin on the release of insulin, glucagon and somatostatin from the isolated, perfused dog pancreas. Acta Endocrinologica (Copenh). 119, 91–98.Google Scholar
  26. Hermansen, K., Yanaihara, N. and Ahren, B. (1989). On the nature of the galanin action on the endocrine pancreas: studies with six galanin fragments in the perfused dog pancreas. Acta Endocrinologica (Copenh). 121, 545–550.Google Scholar
  27. Hramiak, I.M., McDonald, T.J., Dupré, J., Grant, D., and Grace, D.M. (1987). Galanin’s effect on insulin release from denervated canine pancreas. Clin. Invest. Med., 10, B67.Google Scholar
  28. Hramiak, I.M., Dupré, J., and McDonald, T.J. (1988). Effects of galanin on insulin responses to hormonal, neuropeptidal and pharmacological stimuli in conscious dogs. Endocrinology, 122, 2486–2491.PubMedCrossRefGoogle Scholar
  29. Hulting, A.-L., Meister, B., Grimelius, L., Nersäll, J., Anggard, A., and Hokfelt, T. (1989). Production of a galanin-like peptide by a human pituitary adenoma: immunohistochemical evidence. Acta Physiol. Scand., 137, 561–562.PubMedCrossRefGoogle Scholar
  30. Kaplan, L.M., Spindel, E.R., Isselbacher, K.J., Chin, W.W. (1988). Tissue-specific expression of the rat galanin gene. Proc. Natl. Acad. Sci. USA. 85, 1065–1069.PubMedPubMedCentralCrossRefGoogle Scholar
  31. Koerker, D.J., Harrison, H.C., Jr., and Goodner, C.J. (1990). Galanin stimulates growth hormone but fails to alter insulin or glucose in baboons. Diabetes. 39, Suppl. 1, 1145.Google Scholar
  32. Kuwahara, A., Ozaki, T., Yanaihara, N. Structural requirements for galanin action in the guinea-pig ileum. (1990). Reg. Pep., 29, 23–29.CrossRefGoogle Scholar
  33. Kwok, Y.N., Verchere, C.B., Mcintosh, C.H.S., and Brown, J.C. (1988). Effect of galanin on endocrine secretions from the isolated perfused rat stomach and pancreas. Eur. J. Pharmacol., 145, 49–54.PubMedCrossRefGoogle Scholar
  34. Lagny-Pourmir, I., Lorinet, A.M., Yanaihara, N., and Laburthe, M. (1989a). Structural requirements for galanin interaction with receptors from pancreatic beta cells and from brain tissue of the rat. Peptides. 10, 757–761.PubMedCrossRefGoogle Scholar
  35. Lagny-Pourmir, I., Amiranoff, B., Lorinet, A.M., Tatemoto, K., and Laburthe, M. (1989b). Characterization of galanin receptors in the insulin-secreting cell line Rin m 5F: evidence for coupling with a pertussis toxin-sensitive guanosine triphosphate regulatory protein. Endocrinology. 124, 2635–2641.PubMedCrossRefGoogle Scholar
  36. Leonhardt, U., Siegel, E.G., Kohler, H., Barthel, M., Tytko, A., Nebendahl, K., and Creutzfeldt, W. (1989). Galanin inhibits glucose-induced insulin release in vitro. Horm. Metabol. Res., 21, 100–101.CrossRefGoogle Scholar
  37. Lindskog, S., and Ahrén, B. (1987). Galanin: effects on basal and stimulated insulin and glucagon secretion in the mouse. Acta. Physiol. Scand., 129, 305–309.PubMedCrossRefGoogle Scholar
  38. Lindskog, S., and Ahrén, B. (1988). Galanin and pancreastatin inhibit stimulated insulin secretion in the mouse: comparison of effects. Hormone Res., 29, 237–240.PubMedCrossRefGoogle Scholar
  39. Manabe, T., Yoshimura, T., Kii, E., Tanaka, Y., Ohshio, G., Tobe, T., Akaji, K., and Yajima, H. (1986). Galanin-induced hyperglycemia: effect on insulin and glucagon. Endo. Res., 12(1), 93–98.CrossRefGoogle Scholar
  40. McDonald, T.J., Dupre, J., Tatemoto, K., Greenberg, G.R., Radziuk, J., and Mutt, V. (1985). Galanin inhibits insulin secretion and induces hyperglycemia in dogs. Diabetes. 34, 192–196.PubMedCrossRefGoogle Scholar
  41. McDonald, T.J., Dupré, J., Greenberg, G.R., Tepperman, F., Brooks, B., Tatemoto, K., and Mutt, V. (1986). The effect of galanin on canine plasma glucose and gastroenteropancreatic hormone responses to oral nutrients and intravenous arginine. Endocrinology. 119, 2340–2345.PubMedCrossRefGoogle Scholar
  42. McDonald, T.J., Rökaeus, Å., Brooks, B.D., Tinner, B., Staines, W.A., Buchan, A., St. Pierre, S. (1989). Pancreatic galanin immunoreactivity (GalLI): content and chromatographic forms. Clin. Invest. Med., 12, Supp., R-129.Google Scholar
  43. Messell, T., Harling, H., Bottcher, G., Johnsen, A.H., and Hoist, J.J. (1990). Galanin in the porcine pancreas. Reg. Pep., 28, 161–176.CrossRefGoogle Scholar
  44. Miralles, P., Peiró, E., Silvestre, R.A., Villaneuva, M.L., and Marco, J. (1988). Effects of galanin on islet cell secretory responses to VIP, GIP, 8-CCK, and glucagon by the perfused rat pancreas. Metabolism. 37, 766–770.PubMedCrossRefGoogle Scholar
  45. Miralles, P., Peiró, E., Dégano, P., Silvestre, R.A., and Marco, J. (1990). Inhibition of insulin and somatostatin secretion and stimulation of glucagon release by homologous galanin in perfused rat pancreas. Diabetes. 39, 996–1001.PubMedCrossRefGoogle Scholar
  46. Mutt, V., Jorpes, J.E. (1967). Isolation of aspartyl-phenylalanine amide from cholecystokinin-pancreozymin. Biochem. Biophys. Res. Com., 26, 392–397.PubMedCrossRefGoogle Scholar
  47. Mutt, V. (1973). In: Endocrinology 1973. The intestinal hormones in 1973. Proceedings of the Fourth International Symposium, William Heinemann Medical Books Ltd., London, 100–116.Google Scholar
  48. 1.
    Mutt, V. (1976). Further investigations on intestinal hormonal polypeptides. Clin. Endocrinol., Suppl. J, 5, 175s–183s.CrossRefGoogle Scholar
  49. Nilsson, T., Arkhammar, P., Rorsman, P., and Berggren, P.-O. (1989). Suppression of insulin release by galanin and somatostatin is meditated by a G-protein. J. Biol. Chem., 264, 973–980.PubMedGoogle Scholar
  50. Porte Jr., D., Hoods, S.C. (1983) Neural regulation of islet hormones and its role in energy balance and stress hyperglycemia. In: Ellenberg, M., Rifkin, H. (eds) Diabetes Mellitus: Theory and Practice. Medical Examination Publishing Co., New York, p 267.Google Scholar
  51. Radziuk, J., Pye, S., Davies, G., and McDonald, T.J. (1990). Differential effects of a graded selective suppression of insulin secretion on glucose production and removal in dogs. Diabetes. 39: Suppl. 1, 357A.Google Scholar
  52. Rökaeus, Å. (1987). Galanin: a newly isolated biologically active neuropeptide. Trends in Neurological Sciences, 10, 158–164.Google Scholar
  53. Rökaeus, Å., McDonald, T.J., Brooks, B.D. and St-Pierre, S. (1988). Galanin: structure-function relations and pancreatic forms. Diabetes, 37, Suppl. 1, 183A.Google Scholar
  54. Rökaeus, Å., and Carlquist, M. (1988). Nucleotide sequence analysis of cDNAs encoding a bovine galanine precursor protein in the adrenal medulla and chemical isolation of bovine gut galanin. FEBS Let., 234, 400–406.CrossRefGoogle Scholar
  55. Schnuerer, E.M., McDonald, T.J., and Dupré, J. (1987). Inhibition of insulin release by galanin and gastrin-releasing peptide in the anaesthetized rat. Reg. Pep., 18, 307–320.CrossRefGoogle Scholar
  56. Schnuerer, E.M., Rökaeus, Å., Carlquist, M., Bergman, T., Dupré, J., and McDonald, T.J. (1990). Rat and porcine galanin are equipotent in inhibiting insulin responses to glucose in the anesthetized rat. Pancreas, 5, 70–74.PubMedCrossRefGoogle Scholar
  57. Sharp, G.W.G., Le Marchand-Brustel, Y., Yada, T., Russo, L.L., Bliss, C.R., Cormont, M., Monge, L., and Van Obberghen, E. (1989). Galanin can inhibit insulin release by a mechanism other than membrane hyperpolarization or inhibition of adenylate cyclase. J. Biol. Chem., 264, 7302–7309.PubMedGoogle Scholar
  58. Silvestre, R.A., Miralles, P., Monge, L., Moreno, P., Villaneuva, M.L., and Marco. J. (1987a). Effects of galanin on hormone secretion from the in situ perfused rat pancreas and on glucose production in rat hepatocytes in vitro. Endocrinology. 121, 378–383.PubMedCrossRefGoogle Scholar
  59. Silvestre, R.A., Miralles, P., Monge, L., Villaneuva, M.L., and Marco, J. (1987b). Inhibitory effect of galanin on pancreatic polypeptide release by the perfused rat pancreas. Life Sciences. 40, 1829–1833.PubMedCrossRefGoogle Scholar
  60. Stagner, J., Samols, E., McDonald, T.J., and Dupré, J. (1986). Local regulation of islet secretion by the neuropeptide galanin. Abstract book of the 68th Annual Meeting of the Endocrine Society, Abstract 950, 268.Google Scholar
  61. Tatemoto, K., and Mutt, V. (1978). Chemical determination of polypeptide hormones, Proc. Nat. Acad. Sc. USA, 75, 4115–4119.CrossRefGoogle Scholar
  62. Tatemoto, K. (1982). Chemical detection: a new way of finding peptides. Discovery of peptide HI, peptide YY and neuropeptide Y. Doctoral Thesis. Department of Biochemistry II, Karolinska Institute, Stockholm, Sweden.Google Scholar
  63. Tatemoto, K., Rokaeus, A., Jornvall, H., McDonald, T.J., and Mutt, V. (1983). Galanin — a novel biologically active peptide from porcine intestine. FEBS Let., 164, 124–128.CrossRefGoogle Scholar
  64. Ullrich, S., and Hollheim, C.B. (1989). Galanin inhibits insulin secretion by direct interference with exocytosis. FEBS Let., 247, 401–404.CrossRefGoogle Scholar
  65. Vrontakis, M.E., Peden, L.M., Duckworth, M.L., Friesen, H.G. (1987). Isolation and characterization of a complementary DNA (galanin) clone from estrogen-induced pituitary tumor messenger RNA. J. Biol. Chem., 262, 16755–16758.PubMedGoogle Scholar
  66. Yoshimura, T., Ishizuka, O., Greeley, G.H., Jr., and Thompson, J.C. (1989). Effect of galanin on glucose-, arginine-, or potassium-stimulated insulin release. Am. J. Phvsiol., 256, E619–623.Google Scholar

Copyright information

© The Wenner-Gren Center 1991

Authors and Affiliations

  • T. J. McDonald
  • B. Tinner
  • W. A. Staines
  • J. Radziuk

There are no affiliations available

Personalised recommendations